Chelation therapy of atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Integrative and Complementary Medicine

Background:

• Atherosclerosis is a significant cause of cardiovascular disease.
• Chelation therapy is being marketed as a non-surgical treatment for atherosclerosis.

Purpose of the Study:

• To review the rationale, clinical efficacy, and safety of chelation therapy for atherosclerotic vascular disease.
• To assess the available evidence supporting chelation therapy.

Main Methods:

• Literature review of studies on chelation therapy for atherosclerosis.
• Analysis of the scientific basis, clinical outcomes, and adverse events associated with edetate disodium chelation therapy.

Main Results:

• The rationale for using chelation therapy in atherosclerosis is based on unproven mechanisms.
• Clinical trials and observational studies do not provide acceptable evidence of efficacy.
• Safety data is limited, and potential risks are not fully elucidated.

Conclusions:

• There is a lack of acceptable scientific evidence to support the use of chelation therapy for atherosclerotic vascular disease.
• Further rigorous research is needed to establish the safety and efficacy of this treatment modality.